Colloquium: Positronium physics and biomedical applications
Positronium is the simplest bound state, built of an electron and a positron. Studies of
positronium in vacuum and its decays in medium tell us about quantum electrodynamics …
positronium in vacuum and its decays in medium tell us about quantum electrodynamics …
Clinical advances in PET–MRI for breast cancer
AM Fowler, RM Strigel - The Lancet Oncology, 2022 - thelancet.com
Imaging is paramount for the early detection and clinical staging of breast cancer, as well as
to inform management decisions and direct therapy. PET–MRI is a quantitative hybrid …
to inform management decisions and direct therapy. PET–MRI is a quantitative hybrid …
PET/CT for patients with breast cancer: where is the clinical impact?
GA Ulaner - American Journal of Roentgenology, 2019 - Am Roentgen Ray Soc
OBJECTIVE. FDG PET/CT affects the management of patients with breast cancer in multiple
settings, including initial staging, treatment response assessment, and evaluation of …
settings, including initial staging, treatment response assessment, and evaluation of …
[HTML][HTML] Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography
Focused ultrasound (FUS) is a minimally-invasive technology used for treatment of many
diseases, including diseases related to the colon, uterus, prostate, and brain. Although it has …
diseases, including diseases related to the colon, uterus, prostate, and brain. Although it has …
Imaging using radiolabelled targeted proteins: Radioimmunodetection and beyond
The use of radiolabelled antibodies was proposed in 1970s for staging of malignant
tumours. Intensive research established chemistry for radiolabelling of proteins and …
tumours. Intensive research established chemistry for radiolabelling of proteins and …
Zirconium immune-complexes for PET molecular imaging: current status and prospects
L Melendez-Alafort, G Ferro-Flores, L De Nardo… - Coordination Chemistry …, 2023 - Elsevier
Diagnostic molecular images, obtained by positron emission tomography (PET), have
successfully functioned as sensitive tools for detecting and monitoring the treatment of …
successfully functioned as sensitive tools for detecting and monitoring the treatment of …
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F] fluoroestradiol (FES), a PET radiotracer …
JA Katzenellenbogen - Nuclear medicine and biology, 2021 - Elsevier
Abstract Introduction 16α-[18 F] Fluoroestradiol (FES), a PET radiotracer for the estrogen
receptor (ER) in breast cancer, was the first receptor-targeted PET radiotracer for oncology …
receptor (ER) in breast cancer, was the first receptor-targeted PET radiotracer for oncology …
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab …
Background Human epidermal growth factor receptor 2 (HER2)-targeted therapies are
successful in patients with HER2-positive malignancies; however, spatial and temporal …
successful in patients with HER2-positive malignancies; however, spatial and temporal …
PET and SPECT imaging of the EGFR family (RTK class I) in oncology
The human epidermal growth factor receptor family (EGFR-family, other designations: HER
family, RTK Class I) is strongly linked to oncogenic transformation. Its members are …
family, RTK Class I) is strongly linked to oncogenic transformation. Its members are …
Molecular classification of breast cancer
M Roy, AM Fowler, GA Ulaner, A Mahajan - PET clinics, 2023 - pet.theclinics.com
Breast cancer is the most common carcinoma in women worldwide. It encompasses a large
and heterogeneous group of tumors. Based on morphologic appearance, most (80%–85%) …
and heterogeneous group of tumors. Based on morphologic appearance, most (80%–85%) …